{
    "nctId": "NCT06311695",
    "briefTitle": "Contrast-Enhanced Spectral Mammography (CESM)",
    "officialTitle": "The Role of Contrast-Enhanced Spectral Mammography (CESM) in the Diagnostic Process of Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 263,
    "primaryOutcomeMeasure": "Evaluation of negative predictive value (NPV) of the CEM",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with breast lesions, who underwent bilateral CEM\n* Histological assessment\n\nExclusion Criteria:\n\n* The subject is known to have risks of adverse effects with iodine contrast agents\n* The subject has breasts too large to be adequately positioned on Full field digital mammography (FFDM) digital receptor without anatomical cut off during an FFDM examination",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}